Free Trial

LivaNova (LIVN) Competitors

$60.04
+0.44 (+0.74%)
(As of 05/28/2024 ET)

LIVN vs. ITGR, CNMD, HAE, TMDX, INMD, SLNO, BLFS, AXGN, OM, and MASI

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Integer (ITGR), CONMED (CNMD), Haemonetics (HAE), TransMedics Group (TMDX), InMode (INMD), Soleno Therapeutics (SLNO), BioLife Solutions (BLFS), AxoGen (AXGN), Outset Medical (OM), and Masimo (MASI). These companies are all part of the "medical" sector.

LivaNova vs.

Integer (NYSE:ITGR) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, community ranking, dividends, risk and analyst recommendations.

99.3% of Integer shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 2.0% of Integer shares are owned by company insiders. Comparatively, 0.3% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Integer has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.

In the previous week, Integer had 3 more articles in the media than LivaNova. MarketBeat recorded 8 mentions for Integer and 5 mentions for LivaNova. Integer's average media sentiment score of 1.16 beat LivaNova's score of 1.05 indicating that LivaNova is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
3 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LivaNova received 3 more outperform votes than Integer when rated by MarketBeat users. Likewise, 68.78% of users gave LivaNova an outperform vote while only 63.41% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
IntegerOutperform Votes
376
63.41%
Underperform Votes
217
36.59%
LivaNovaOutperform Votes
379
68.78%
Underperform Votes
172
31.22%

Integer presently has a consensus target price of $128.00, indicating a potential upside of 5.49%. LivaNova has a consensus target price of $66.20, indicating a potential upside of 10.26%. Given Integer's higher probable upside, analysts plainly believe LivaNova is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
LivaNova
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

Integer has higher revenue and earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.63B2.49$90.65M$2.8941.99
LivaNova$1.15B2.82$17.55M-$0.60-100.07

Integer has a net margin of 6.01% compared to Integer's net margin of -2.68%. Integer's return on equity of 13.59% beat LivaNova's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.01% 11.25% 5.69%
LivaNova -2.68%13.59%7.06%

Summary

Integer beats LivaNova on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$3.25B$3.17B$5.00B$8.09B
Dividend YieldN/A1.68%2.74%3.96%
P/E Ratio-100.079.67176.4818.43
Price / Sales2.8272.052,386.6172.31
Price / Cash13.8570.7633.0728.77
Price / Book2.533.904.944.39
Net Income$17.55M$84.42M$104.35M$213.55M
7 Day Performance-0.83%-0.94%-0.63%-0.80%
1 Month Performance8.12%17.40%3.85%3.42%
1 Year Performance36.39%-5.64%5.47%7.53%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
2.4976 of 5 stars
$121.83
+0.2%
$128.00
+5.1%
+51.0%$4.08B$1.63B42.1610,500Insider Selling
Positive News
CNMD
CONMED
4.9227 of 5 stars
$73.10
-2.5%
$102.50
+40.2%
-37.0%$2.25B$1.24B28.014,000Dividend Announcement
Short Interest ↑
HAE
Haemonetics
4.2252 of 5 stars
$88.64
-1.6%
$108.67
+22.6%
+7.0%$4.51B$1.31B38.713,657Analyst Revision
High Trading Volume
TMDX
TransMedics Group
2.4819 of 5 stars
$137.53
+0.4%
$119.00
-13.5%
+102.1%$4.53B$241.62M-404.50584Positive News
INMD
InMode
1.9725 of 5 stars
$18.45
-3.4%
$32.80
+77.8%
-39.1%$1.55B$492.05M8.74581Short Interest ↑
SLNO
Soleno Therapeutics
4.2809 of 5 stars
$41.17
-4.0%
$60.33
+46.5%
+676.8%$1.38BN/A-15.3633
BLFS
BioLife Solutions
0.3375 of 5 stars
$21.09
-3.6%
$23.67
+12.2%
-1.6%$970.77M$143.27M-14.85409Short Interest ↑
AXGN
AxoGen
2.4211 of 5 stars
$6.11
-1.5%
$10.67
+74.6%
-25.3%$267.04M$163.73M-12.22426Positive News
Gap Up
OM
Outset Medical
1.4809 of 5 stars
$3.99
+2.3%
$5.42
+35.8%
-81.4%$206.36M$130.38M-1.18480Positive News
MASI
Masimo
4.3407 of 5 stars
$124.75
-1.5%
$138.71
+11.2%
-19.2%$6.62B$2.05B84.865,200Short Interest ↓
Positive News

Related Companies and Tools

This page (NASDAQ:LIVN) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners